|
|||||
|
|
Rosiglitazone does not improve cognition or global function when used as adjunctive therapy to AChE inhibitors in mild-to-moderate Alzheimer's disease: two phase 3 studies |
|
| Authors: | Harrington C Sawchak S Chiang C Davies J Donovan C Saunders A M Irizarry M Jeter B Zvartau-Hind M van Dyck C H Gold M |
| Affiliation: | Neurosciences Medicines Development Center, GlaxoSmithKline, Research Triangle Park, NC, USA. conn.m.harrington@gsk.com |
| Abstract: | |
| Keywords: | |
| 本文献已被 PubMed 等数据库收录！ | |